Argonaute RNA

ScionxBio

This biotechnology company develops long-acting RNA medicines for pharmaceutical partners and patients with cardio-metabolic diseases.

Starna Therapeutics

This biotechnology company develops messenger RNA medicines and extrahepatic delivery systems for pharmaceutical firms and clinical researchers.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

ADARx Pharmaceuticals

This clinical-stage biotechnology company develops RNA-targeting therapeutics for patients with genetic, cardiometabolic, complement-mediated, and central nervous system diseases.

Altamira Therapeutics

This company develops peptide-based nanoparticle technologies for RNA delivery to pharmaceutical industry partners developing treatments for cancer and inflammatory diseases.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Breeze

This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.